|
Test data suggests that nasal treatment with SinoFresh decreased the severity and/or
incidence of H1N1 infection in test group animals.
|
|
VENICE, Fla., SinoFresh Healthcare Products, Inc. announced today the successful
results of its initial pilot animal study testing the efficacy of the SinoFresh
Nasal Spray product when used on animals infected with the H1N1 ("swine flu") virus.
The study data suggests that treatment with SinoFresh allowed the infected animals
to recover more rapidly from H1N1 infection than did untreated animals. In addition,
pre-treatment with SinoFresh Nasal Spray decreased the severity and/or incidence
of infection.
|
|
Dr. Michael Stampar, D.O., Senior Medical Advisor to SinoFresh Healthcare Products,
stated, "We are very encouraged by this initial study report and will continue to
develop data to support our belief that SinoFresh Nasal Spray, a broad based antiseptic
solution is an important component in protecting the health of patients that are
exposed to the H1N1 ('swine flu') virus."
|
|
The study which was conducted by SRS International Corp of Falls Church VA. was
conducted over 14 days and was designed to evaluate the severity of infection from
H1N1 ("swine flu") virus in the Cotton Rat animal model, a well accepted model for
studying human nasal and respiratory tract infection by viruses and other microbial
pathogens. In this study, the test animals were inoculated with H1N1 and then received
SinoFresh Nasal Spray in the nose three times daily for 14 days. The study evaluated
the product's likelihood of efficacy in both prevention and treatment. One group
of animals was treated with SinoFresh Nasal Spray prior to inoculation with H1N1
and a second group was treated starting 15 minutes after inoculation with H1N1 while
the remaining "control group" received no treatment during the overall 14 day study
period.
|
|
The Company has now also initiated a study to evaluate the product's ability to
reduce or eliminate viral shedding which is the main method of transmission of the
H1N1 flu virus. The active phase of the additional study has been completed and
is in the laboratory for evaluation. Results are expected in the next few weeks.
SinoFresh Healthcare Products, Inc. is a privately held exclusive marketer of innovative
upper respiratory system therapies.
|
|
The Company uses broad-spectrum antiseptic approaches to reduce viral, bacterial,
and fungal organisms that are suspected to cause pathogenesis of the mouth, nose,
and throat. The Company's lead product, SinoFresh Nasal Spray, is a hygienic cleansing
spray that kills germs and removes other nasal-sinus irritants. This product and
a planned series of follow-on products built on the Company's proprietary technology
will, in time, exploit an enormous global opportunity for the SinoFresh product
line as people begin to understand the benefit of using a daily preventative antiseptic
product that can actually address the causes of diseases in the upper respiratory
area.
|
|